ArticleThe international journal of neuropsychopharmacology2016

The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.

Aliou B Gueye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.